Related Experiment Video
Updated: Jan 29, 2026

Expression Analysis of Mammalian Linker-histone Subtypes
Published on: March 19, 2012
The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability
Rachel H Tan1, Boris Guennewig2, Carol Dobson-Stone2
1From the Brain and Mind Centre and Central Clinical School (R.H.T., B.G., C.D.-S., J.B.J.K., M.C.K., J.R.H., G.M.H.) and School of Medical Sciences (J.J.K.), Faculty of Medicine and Health, and Brain and Mind Centre and School of Psychology (O.P.), The University of Sydney; School of Medical Sciences (R.H.T., C.D.-S., G.M.H.), University of New South Wales & Neuroscience Research Australia; Department of Neurology (M.C.K.), Royal Prince Alfred Hospital; ARC Centre of Excellence in Cognition and its Disorders (J.R.H., O.P.); and Division of Neuroscience (B.G.), Garvan Institute of Medical Research and St Vincent's Clinical School, UNSW Sydney, New South Wales, Australia. rachel.tan1@sydney.edu.au.
Amyotrophic lateral sclerosis (ALS) occurs in 12% of primary progressive aphasia (PPA) patients. This study highlights the crucial link between PPA and ALS, emphasizing the need for ALS screening in PPA cases.
Area of Science:
- Neuroscience
- Genetics
- Neuropathology
Background:
- Primary progressive aphasia (PPA) is a neurodegenerative condition affecting language. Amyotrophic lateral sclerosis (ALS) is a motor neuron disease. The overlap and genetic underpinnings between PPA and ALS require further investigation.
- Frontotemporal lobar degeneration (FTLD) is a key pathology in PPA and ALS, with TDP-43 proteinopathy (FTLD-TDP) being a common subtype.
Purpose of the Study:
- To determine the incidence and heritability of ALS in a large Australian cohort of patients with PPA.
- To investigate the neuropathology, including FTLD-TDP, associated with PPA-ALS.
- To identify genetic factors contributing to PPA and PPA-ALS, particularly in familial cases.
Main Methods:
- A cohort of 130 patients with nonfluent (nfvPPA) or semantic (svPPA) variants of PPA were assessed for ALS and family history of neurodegenerative diseases.
- Neuropathologic examination was performed on autopsy cases (n=36).
- Genetic analysis was conducted on familial PPA and PPA-ALS cases to identify mutations in known FTD/ALS genes.
Main Results:
- ALS was present in 18% of nfvPPA and 5% of svPPA cases. Overall, 12% of the PPA cohort had concomitant ALS.
- A strong family history was associated with PPA-ALS and FTLD-TDP pathology.
- FTLD-TDP was found in all PPA-ALS autopsy cases. Genetic analysis revealed mutations in known FTD/ALS genes in familial PPA, but only 50% of familial PPA-ALS cases, suggesting novel genetic variants.
Conclusions:
- The incidence of ALS in PPA is significant (12%), comparable to overall FTD rates, indicating a substantial proportion of FTD-ALS patients present with primary language deficits.
- Assessing for ALS in PPA patients is critical, as PPA-ALS demonstrates a strong clinicopathologic association.
- The genetic landscape of PPA-ALS may involve novel genetic variants beyond those currently known in FTD/ALS genes.
Related Concept Videos
Heritability
Titration Calculations: Strong Acid - Strong Base
A titration is carried out for 25.00 mL of 0.100 M HCl (strong acid) with 0.100 M of a strong base NaOH. The pH at different volumes of added base solution can be calculated as follows:
(a) Titrant volume = 0 mL. The solution pH is due to the acid ionization of HCl. Because this is a strong acid, the ionization is complete and the hydronium ion molarity is 0.100 M. The pH of the solution is then:
Other Unique Bacteria
Strong Acid and Base Solutions
Second Uniqueness Theorem
In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
Titration of a Strong Acid with a Strong Base

